Cite

HARVARD Citation

    Winkelmann, N. et al. (n.d.). Recurrent CEP85L–PDGFRB fusion in patient with t(5;6) and imatinib-responsive myeloproliferative neoplasm with eosinophilia. Leukemia & lymphoma. 54 (7), pp. 1527-1531. [Online]. 
  
Back to record